Description

This deliverable provides insights on the many macro issues facing the life sciences industry which have resulted in consolidation and an increasing number in partnerships. This research service presents merger and acquisition activity by select life sciences participants and business strategies for new drug development, including contract research organization (CRO) and open innovation partnerships.